Market revenue in 2022 | USD 2.9 million |
Market revenue in 2030 | USD 5.2 million |
Growth rate | 7.6% (CAGR from 2022 to 2030) |
Largest segment | Blood culture media |
Fastest growing segment | Assay Kits & Reagents |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Blood culture media was the largest segment with a revenue share of 37.93% in 2022. Horizon Databook has segmented the Kuwait sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
In Kuwait, diagnosing sepsis involves a combination of clinical examination, laboratory tests, and imaging studies. Blood cultures are crucial in identifying the infectious agent responsible for sepsis and septic shock. Additional laboratory tests, including a complete blood count, kidney function tests, and inflammatory markers, are used to diagnose sepsis and gauge its severity.
Imaging techniques such as chest X-ray, ultrasound, or CT scans help locate the infection source or assess organ dysfunction. Once sepsis or septic shock is diagnosed, treatment with antibiotics, fluid resuscitation, and supportive care are promptly initiated to enhance patient recovery.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account